Financial insights of ODYY

MyFinsight

Income Statement	2026-04-30	2026-01-31	2025-10-31	2025-07-31
Research and development expense	NaN	NaN	NaN	0*
General and administrative expense	297,554	181,942	303,190	255,188.25*
Loss from operations	-297,554	-181,942	-303,190	-255,188.25*
Gain on sale of product candidates and related assets	NaN	NaN	NaN	0*
Impairment of investment in preferred stock of oragenics, inc	NaN	NaN	NaN	0*
Loss from change in fair value of oragenics, inc. common stock	0	0	0	-114,854.25*
Interest expense	527,551	412,429	95,336	63,129*
Financing costs	0	2,572,655	507,368	NaN
Change in fair value of derivative liability	1,505,581	-424,348	422,419	NaN
Gain on extinguishment of accounts payable	85,369	NaN	NaN	NaN
Other income (expense), net	45	-10,249	28	-2,501.25*
Net income (loss) and comprehensive income (loss)	765,890	-3,601,623	-483,447	-435,672.75*
Deemed dividend	NaN	NaN	NaN	0*
Net loss attributable to common stockholders	NaN	NaN	NaN	-435,672.75

Basic EPS	0.01	-0.03	0	-0.004
Diluted EPS	0.01	-0.03	0	-0.004
Basic Average Shares	108,031,419	107,853,763	106,036,632	104,709,763
Diluted Average Shares	186,674,907	107,853,763	106,036,632	104,709,763

Unit: Dollar. Numbers labeled with * are estimated quarterly values.